Kristina M. Herbert

ORCID: 0000-0002-5288-3381
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • DNA and Nucleic Acid Chemistry
  • Advanced biosensing and bioanalysis techniques
  • interferon and immune responses
  • RNA Research and Splicing
  • RNA and protein synthesis mechanisms
  • RNA Interference and Gene Delivery
  • HIV Research and Treatment
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Computational Drug Discovery Methods
  • Bacterial Genetics and Biotechnology
  • Respiratory viral infections research
  • Herpesvirus Infections and Treatments
  • Protein Structure and Dynamics
  • Viral Infections and Immunology Research
  • MicroRNA in disease regulation
  • Force Microscopy Techniques and Applications
  • Influenza Virus Research Studies
  • Advanced Fluorescence Microscopy Techniques
  • CRISPR and Genetic Engineering
  • Viral gastroenteritis research and epidemiology
  • PARP inhibition in cancer therapy
  • Photosynthetic Processes and Mechanisms
  • Parvovirus B19 Infection Studies
  • Biosimilars and Bioanalytical Methods

Sanford Burnham Prebys Medical Discovery Institute
2017-2024

Discovery Institute
2017-2024

Center for Scientific Research and Higher Education at Ensenada
2015-2016

Ensenada Institute of Technology
2016

Howard Hughes Medical Institute
2013-2015

Yale University
2011-2015

Stanford University
2006-2010

European Molecular Biology Laboratory
2002

University of Pennsylvania
2001

Recent studies have profiled the innate immune signatures in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and suggest that cellular responses to viral challenge may affect disease severity. Yet molecular events underlie recognition response SARS-CoV-2 infection remain be elucidated. Here, we find replication induces a delayed interferon (IFN) lung epithelial cells. By screening 16 putative sensors involved sensing of RNA virus infection, found MDA5 LGP2...

10.1016/j.celrep.2020.108628 article EN cc-by Cell Reports 2021-01-01

Abstract The emergence of novel SARS coronavirus 2 (SARS-CoV-2) in 2019 has triggered an ongoing global pandemic severe pneumonia-like disease designated as (COVID-19). To date, more than 2.1 million confirmed cases and 139,500 deaths have been reported worldwide, there are currently no medical countermeasures available to prevent or treat the disease. As development a vaccine could require at least 12-18 months, typical timeline from hit finding drug registration antiviral is >10 years,...

10.1101/2020.04.16.044016 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2020-04-17

During miRNA biogenesis, the microprocessor complex (MC), which is composed minimally of Drosha, an RNase III enzyme, and DGCR8, a double-stranded RNA-binding protein, cleaves primary (pri-miRNA) in order to release pre-miRNA stem-loop structure. Using phosphoproteomics, we mapped 23 phosphorylation sites on full-length human DGCR8 expressed insect or mammalian cells. can be phosphorylated by mitogenic ERK/MAPK, indicating that may respond integrate extracellular cues. The expression...

10.1016/j.celrep.2013.10.017 article EN cc-by-nc-nd Cell Reports 2013-11-01

Many viral pathogens target innate sensing cascades and/or cellular transcription factors to suppress antiviral immune responses. Here, we show that the accessory protein U (Vpu) of HIV-1 exerts broad immunosuppressive effects by inhibiting activation factor NF-κB. Global transcriptional profiling infected CD4 +T cells revealed vpu-deficient strains induce substantially stronger responses than respective wild type viruses. Gene set enrichment analyses and cytokine arrays showed Vpu...

10.7554/elife.41930 article EN cc-by eLife 2019-02-05

The chaperone Hsp90 is required for the correct folding and maturation of certain "client proteins" within all cells. Hsp90-mediated particularly important in cancer cells, because upregulated or mutant oncogenic proteins are often clients. inhibitors thus represent a route to anticancer agents that have potential be active against several different types cancer. Currently, various bind at its ATP-binding site preclinical clinical trials. Some most promising well characterized geldanamycin...

10.1021/mp200346y article EN Molecular Pharmaceutics 2011-09-01

During microRNA (miRNA) biogenesis, the Microprocessor complex (MC), composed minimally of Drosha, an RNaseIII enzyme, and DGCR8, a double-stranded RNA-binding protein, cleaves primary-miRNA (pri-miRNA) to release pre-miRNA stem-loop structure. Size-exclusion chromatography MC, isolated from mammalian cells, suggested multiple copies one or both proteins in complex. However, exact stoichiometry was unknown. Initial experiments that DGCR8 bound pri-miRNA substrates specifically, given Drosha...

10.1261/rna.054684.115 article EN RNA 2015-12-18

Mouse embryonic stem cells (mESCs) deficient for DGCR8, a key component of the microprocessor complex, present strong differentiation defects. However, exact reasons impairing their commitment remain elusive. The analysis newly generated mutant mESCs revealed that DGCR8 is essential exit from pluripotency state. To dissociate canonical versus noncanonical functions we complemented with phosphomutant which restored microRNA levels but did not rescue defect. Integration omics data and RNA...

10.1083/jcb.201606073 article EN cc-by-nc-sa The Journal of Cell Biology 2017-01-18

The Epstein-Barr virus (EBV)-encoded noncoding RNAs EBER1 and EBER2 are highly abundant through all four latency stages of EBV infection (III-II-I-0) have been associated with an oncogenic phenotype when expressed in cell lines cultured vitro. In vivo, EBV-infected B cells derived from freshly isolated lymphocytes show that EBER1/2 deletion does not impair viral latency. Based on published quantitative proteomics data BJAB expressing EBER2, we propose the EBERs, their activation AKT a...

10.1128/mbio.01926-15 article EN cc-by-nc-sa mBio 2016-01-20

Recent studies profiling the innate immune signatures in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) suggest that cellular responses to viral challenge impact disease severity. Yet, molecular events underlie recognition and response SARS-CoV-2 infection remains be elucidated. Here, we find replication induces a delayed interferon (IFN) lung epithelial cells. Through survey of putative sensors involved detection RNA virus infection, found MDA5 LGP2...

10.2139/ssrn.3682826 article EN SSRN Electronic Journal 2020-01-01

Influenza A virus (IAV) is a human respiratory pathogen that causes yearly global epidemics, as well sporadic pandemics due to adaptation of pathogenic strains. Efficient replication IAV in different species is, part, dictated by its ability exploit the genetic environment host cell. To investigate tropism cells, we evaluated strains diverse subset epithelial cell lines. HeLa cells were refractory growth H1N1 and H3N2 viruses low-pathogenic avian influenza (LPAI) viruses. Interestingly,...

10.1128/jvi.01410-19 article EN Journal of Virology 2019-11-26
Coming Soon ...